Vinpocetine
Cavinton Forte contains the active substance vinpocetine.
Vinpocetine is a compound used in the treatment of diseases or alleviation of symptoms related to
blood circulation disorders in the brain.
Indications for use of Cavinton Forte:
Before starting to use Cavinton Forte, you should discuss it with your doctor or pharmacist.
If the patient has certain heart diseases, the doctor will recommend performing control ECG tests
(electrocardiologic examination - examination of heart function). This is especially important in patients who have been diagnosed with QT interval prolongation or in patients who are also taking medications that cause QT interval prolongation.
The use of this medicine is contraindicated in children and adolescents due to the lack of sufficient clinical trial data in this age group.
You should tell your doctor or pharmacist about all the medicines you are currently taking or have recently taken, as well as any medicines you plan to take.
Cavinton Forte may interfere with the action of other medicines or other medicines may affect its action.
You should tell your doctor, especially if you are taking the following medicines:
Cavinton Forte should be taken after meals.
If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, you should consult your doctor or pharmacist before using this medicine.
If you are of childbearing age, you must use an effective contraceptive method during treatment with Cavinton Forte. Otherwise, the administration of vinpocetine is contraindicated.
Cavinton Forte is contraindicated during pregnancy and breastfeeding.
There is no data on the effect of vinpocetine on the ability to drive and use machines.
If you have been diagnosed with intolerance to some sugars, you should contact your doctor before taking the medicine.
This medicine should always be used as directed by your doctor. If you are unsure, you should consult your doctor or pharmacist.
The usual dose of Cavinton Forte is 1 tablet (10 mg) three times a day (30 mg).
Tablets should be taken after meals.
The dividing line on the tablet is not intended for breaking the tablet.
There is no need to change the dose if the patient has kidney or liver function disorders.
There is no need to change the dose if the patient is over 65 years old.
If you have taken a higher dose of Cavinton Forte than recommended, you should immediately consult your doctor or go to the nearest hospital.
You should not take a double dose to make up for a missed dose. The next dose of the medicine should be taken at the usual time.
If you have any further doubts about using this medicine, you should consult your doctor or pharmacist .
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The side effects listed below are grouped by frequency of occurrence.
Uncommon side effects (may occur in up to 1 in 100 people):
Rare side effects (may occur in up to 1 in 1000 people):
If you experience any side effects, including any side effects not listed in this leaflet, you should tell your doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
By reporting side effects, you can help gather more information on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
There are no special recommendations for storage temperature.
Store in the original packaging to protect from light.
Do not use this medicine after the expiry date stated on the packaging.
The expiry date refers to the last day of the month stated.
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
White or almost white tablets, flat in the shape of a disc, with beveled edges, approximately 8 mm in diameter, with the inscription "10 mg" on one side and a dividing line on the other side.
The medicine is packaged in PVC/Al blisters in a cardboard box.
The cardboard box contains 30 or 90 tablets.
For more detailed information, you should contact the marketing authorization holder or the parallel importer.
Gedeon Richter România S.A.
Str. Cuza Vodă Nr. 99-105
540306 Târgu-Mureş, Romania
Gedeon Richter Plc.
Gyömrői út 19-21
1103 Budapest, Hungary
Medezin Sp. z o.o.
ul. Zbąszyńska 3
91-342 Łódź
Medezin Sp. z o.o.
ul. Zbąszyńska 3
91-342 Łódź
CEFEA Sp. z o.o. Sp. komandytowa
ul. Działkowa 56
02-234 Warsaw
SHIRAZ PRODUCTIONS Sp. z o.o.
ul. Tymiankowa 24/28
95-054 Ksawerów
CANPOLAND SPÓŁKA AKCYJNA
ul. Beskidzka 190
91-610 Łódź
Marketing authorization number in Romania, the country of export: 8306/2015/01
8306/2015/02
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.